Background. Previous studies on the role of inflammation in the pathophysiology of sickle cell disease (SCD) suggested that the CCR5Δ32 allele, which is responsible for the production of truncated C-C chemokine receptor type 5 (CCR5), could confer a selective advantage on patients with SCD because it leads to a less efficient Th1 response. We determined the frequency of the CCR5Δ32 polymorphism in 795 Afro-Brazilian SCD patients followed up at the Pernambuco Hematology and Hemotherapy Center, in Northeastern Brazil, divided into a pediatric group (3 months-17 years, n = 483) and an adult group (18-70 years, n = 312). The adult patients were also compared to a healthy control group (blood donors, 18-61 years, n = 247). Methods. The CCR5/CCR5Δ32 polymorphism was determined by allele-specific PCR. Results. No homozygous patient for the CCR5Δ32 allele was detected. The frequency of heterozygotes in the study population (patients and controls) was 5.8%, in the total SCD patients 5.1%, in the children 5.4%, in the adults with SCD 4.8%, and in the adult controls 8.1%. These differences did not reach statistical significance. Conclusions. Our findings failed to demonstrate an important role of the CCR5Δ32 allele in the population sample studied here.2014 Steinberg, M.H., Pathophysiologically based drug treatment of sickle cell disease (2006) Trends in Pharmacological Sciences, 27 (4), pp. 204-210Steinberg, M.H., Sickle cell anemia, the firstmolecular disease: Overviewofmolecular etiology, pathophysiology, and therapeutic approaches (2008) The Scientific World Journal, 8, pp. 1295-1324Marotta, C.A., Wilson, J.T., Forget, B.J., Weissman, S.M., Human β globin messenger RNA III. Nucleotide sequences derived from complementary DNA (1977) The Journal of Biological Chemistry, 252 (14), pp. 5040-5053Steinberg, M.H., Brugnara, C., Pathophysiological-based approaches to treatment of sickle cell disease (2003) Annual Review of Medicine, 54, pp. 89-112De Sonati, M.F., Costa, F.F., The genetics of blood disorders: Hereditary hemoglobinopathies (2008) Jornal de Pediatria, 84 (4), pp. S40-S51Zago, M.A., Pinto, A.C.S., The pathophysiology of sickle cell disease: From the genetic mutation to multiorgan disfunction (2007) Revista Brasileira de Hematologia e Hemoterapia, 29 (3), pp. 207-214Embury, S.H., The not-so-simple process of sickle cell vasoocclusion (2004) Microcirculation, 11 (2), pp. 101-113Rees, D.C., Williams, T.N., Gladwin, M.T., Sickle-cell disease (2010) The Lancet, 376 (9757), pp. 2018-2031Kutlar, A., Sickle cell disease: A multigenic perspective of a single-gene disorder (2005) Medical Principles and Practice, 14, pp. 15-19Chies, J.A.B., Nardi, N.B., Sickle cell disease: A chronic inflammatory condition (2001) Medical Hypotheses, 57 (1), pp. 46-50Hebbel, R.P., Osarogiagbon, R., Kaul, D., The endothelial biology of sickle cell disease: Inflammation and a chronic vasculopathy (2004) Microcirculation, 11 (2), pp. 129-151Vargas, A.E., Marrero, A.R., Salzano, F.M., Bortolini, M.C., Chies, J.A.B., Frequency of CCR5Δ32 in Brazilian populations (2006) Brazilian Journal of Medical and Biological Research, 39 (3), pp. 321-325Liu, R., Paxton, W.A., Choe, S., Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection (1996) Cell, 86 (3), pp. 367-377Benkirane, M., Jin, D.-Y., Chun, R.F., Koup, R.A., Jeang, K.-T., Mechanism of transdominant inhibition of CCR5-mediated HIV-1 infection by ccr5Δ32 (1997) The Journal of Biological Chemistry, 272 (49), pp. 30603-30606Chies, J.A.B., Hutz, M.H., High frequency of the CCR5delta32 variant among individuals from an admixed Brazilian population with sickle cell anemia (2003) Brazilian Journal of Medical and Biological Research, 36 (1), pp. 71-75Lidén, K., Linderholm, A., Götherström, A., Pushing it back. Dating the CCR5-D32 bp deletion to the Mesolithic in Sweden and its implications for the Meso/Neo transition (2006) Documenta Praehistorica, 33, pp. 29-37Samson, M., Libert, F., Doranz, B.J., Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene (1996) Nature, 382 (6593), pp. 722-726Libert, F., Cochaux, P., Beckman, G., The Δccr5 mutation conferring protection against HIV-1 in Caucasian populations has a single and recent origin in Northeastern Europe (1998) Human Molecular Genetics, 7 (3), pp. 399-406Lucotte, G., Frequencies of 32 base pair deletion of the (Δ32) allele of the CCR5 HIV-1 co-receptor gene in Caucasians: A comparative analysis (2002) Infection, Genetics and Evolution, 1 (3), pp. 201-205Galvani, A.P., Novembre, J., The evolutionary history of the CCR5-Delta32 HIV-resistance mutation (2005) Microbes and Infection, 7 (2), pp. 302-309Vargas, A.E., Cechim, G., Correa, J.F., Pros and cons of a missing chemokine receptor-Comments on "Is the European spatial distribution of the HIV-1-resistant CCR5-Δ32 allele formed by a breakdown of the pathocenosis due to the historical Roman expansion?" by Eric Faure and Manuela Royer-Carenzi (2008) (2009) Infection, Genetics and Evolution, 9 (4), pp. 387-389Faure, E., Royer-Carenzi, M., Is the European spatial distribution of the HIV-1-resistant CCR5-Δ32 allele formed by a breakdown of the pathocenosis due to the historical Roman expansion? (2008) Infection, Genetics and Evolution, 8 (6), pp. 864-874Martinson, J.J., Chapman, N.H., Rees, D.C., Liu, Y.-T., Clegg, J.B., Global distribution of the CCR5 gene 32-basepair deletion (1997) Nature Genetics, 16 (1), pp. 100-103Carvalhaes, F.A.D.P.L., Cardoso, G.L., Hamoy, I.G., Yan, T.L., Guerreiro, J.F., Distribution of CCR5-Δ32, CCR2-64I, and SDF1-3′A mutations in populations from the Brazilian Amazon region (2004) Human Biology, 76 (4), pp. 643-646Carvalho, M.W.P., Leboute, A.P.M., Oliveira, S.F., Sousa, S.M.B., De Nazaré Klautau-Guimarães, M., Simões, A.L., CCR5D32 mutation in three Brazilian populations of predominantly Sub-Saharan African ancestry (2004) Genetics and Molecular Biology, 27 (3), pp. 321-325Boldt, A.B.W., Culpi, L., Tsuneto, L.T., Souza, I.R., Kun, J.F.J., Petzl-Erler, M.L., Analysis of the CCR5 gene coding region diversity in five South American populations reveals two new non-synonymous alleles in Amerindians and high CCR5∗D32 frequency in Euro-Brazilians (2009) Genetics and Molecular Biology, 32 (1), pp. 12-19Teixeira, S.L.M., Bastos, F.I., Hacker, M.A., Morgado, M.G., Distribution of CCR5 genotypes and HLA Class I B alleles in HIV-1 infected and uninfected injecting drug users from Rio de Janeiro, Brazil (2009) Infection, Genetics and Evolution, 9 (4), pp. 638-642Vieira, V.C., Barral, M.F.M., Mendoza-Sassi, R.A., Silveira, J.M., Soares, M.A., De Martínez, A.M.B., The effect of combined polymorphisms in chemokines and chemokine receptors on the clinical course of HIV-1 infection in a Brazilian population (2011) Memórias Do Instituto Oswaldo Cruz, 106 (4), pp. 408-415Grimaldi, R., Shindo, N., Acosta, A.X., Prevalence of the CCR5Δ32 mutation in Brazilian populations and cell susceptibility to HIV-1 infection (2002) Human Genetics, 111 (1), pp. 102-104Rigato, P.O., Hong, M.A., Casseb, J., Better CD4+ T cell recovery in Brazilian HIV-infected individuals under HAART due to commulative carriage of SDF-1-3′ A, CCR2-V64I, CCR5-D32 and CCR5-promoter 59029A/G Polymorphisms (2008) Current HIV Research, 6 (5), pp. 466-473Hünemeier, T., Neves, A.G., Nornberg, I., T-cell and chemokine receptor variation in South Amerindian populations (2005) American Journal of Human Biology, 17 (4), pp. 515-518De Farias, J.D., Santos, M.G., De Franc¸a, A.K., Distribution of the CCR5delta32 allele (gene variant CCR5) in Rondônia, Western Amazonian region, Brazil (2012) Genetics and Molecular Biology, 35 (1), pp. 27-31Jones, K.L., Maguire, J.J., Davenport, A.P., Chemokine receptor CCR5: From AIDS to atherosclerosis (2011) British Journal of Pharmacology, 162 (7), pp. 1453-1469Pichenot, M., Deuffic-Burban, S., Cuzin, L., Yazdanpanah, Y., Efficacy of new antiretroviral drugs in treatment-experienced HIV-infected patients: A systematic review and meta-analysis of recent randomized controlled trials (2012) HIV Medicine, 13 (3), pp. 148-155Dorr, P., Westby, M., Dobbs, S., Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity (2005) Antimicrobial Agents and Chemotherapy, 49 (11), pp. 4721-4732Karaali, Z.E., Sozen, S., Yurdum, M., Effect of genetic variants of chemokine receptors on the development of myocardial infarction in Turkish population (2010) Molecular Biology Reports, 37 (7), pp. 3615-3619Zhao, Q., Dual targeting of CCR2 and CCR5: Therapeutic potential for immunologic and cardiovascular diseases (2010) Journal of Leukocyte Biology, 88 (1), pp. 41-55Zapico, I., Coto, E., Rodríguez, A., Alvarez, C., Torre, J.C., Alvarez, V., CCR5 (chemokine receptor-5) DNA-polymorphism influences the severity of rheumatoid arthritis (2000) Genes & Immunity, 1 (4), pp. 288-289Zúñiga, J.A., Villareal-Garza, C., Flores, E., Biological relevance of the polymorphism in the CCR5 gene in refractory and non-refractory rheumatoid arthritis in Mexicans (2003) Clinical and Experimental Rheumatology, 21 (3), pp. 351-354Petrek, M., Cermáková, Z., Hutyrová, B., CC chemokine receptor 5 and interleukin-1 receptor antagonist gene polymorphisms in patients with primary Sjögren's syndrome (2002) Clinical and Experimental Rheumatology, 20 (5), pp. 701-703Srivastava, P., Helms, P.J., Stewart, D., Main, M., Russell, G., Association of CCR5δ32 with reduced risk of childhood but not adult asthma (2003) Thorax, 58 (3), pp. 222-226Vargas, A.E., Da Silva, M.A.L., Silla, L., Chies, J.A.B., Polymorphisms of chemokine receptors and eNOS in Brazilian patients with sickle cell disease (2005) Tissue Antigens, 66 (6), pp. 683-690